While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

Most people have missed a dose of prescription medication at some point. But if you are taking a glucagon-like peptide-1 drug ...

One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level Mr. Shah Coherent Market Insights Pvt.

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 receptor a ...

2024年11月23日，先为达生物发布消息——收到国家药品监督管理局下发的《受理通知书》，公司提交的1类新药伊诺格鲁肽注射液（Ecnoglutide Injection）成人2型糖尿病患者血糖控制的适应症上市许可申请获国家药品监督管理局受理。关于伊诺格鲁肽注射液（Ecnoglutide ...

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...

The most negatively impacted sectors are frozen, refrigerated, general food and beverages. Circana found GLP-1 users’ monthly ...